Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Brief strengths-based case management promotes entry into HIV medical care: results of the antiretroviral treatment access study-II.

Craw JA, Gardner LI, Marks G, Rapp RC, Bosshart J, Duffus WA, Rossman A, Coughlin SL, Gruber D, Safford LA, Overton J, Schmitt K.

J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):597-606. doi: 10.1097/QAI.0b013e3181684c51.

PMID:
18285714
2.

Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care.

Gardner LI, Metsch LR, Anderson-Mahoney P, Loughlin AM, del Rio C, Strathdee S, Sansom SL, Siegal HA, Greenberg AE, Holmberg SD; Antiretroviral Treatment and Access Study Study Group.

AIDS. 2005 Mar 4;19(4):423-31.

PMID:
15750396
3.

Effect of case management on unmet needs and utilization of medical care and medications among HIV-infected persons.

Katz MH, Cunningham WE, Fleishman JA, Andersen RM, Kellogg T, Bozzette SA, Shapiro MF.

Ann Intern Med. 2001 Oct 16;135(8 Pt 1):557-65.

PMID:
11601927
4.

Factors associated with use of HIV primary care among persons recently diagnosed with HIV: examination of variables from the behavioural model of health-care utilization.

Anthony MN, Gardner L, Marks G, Anderson-Mahoney P, Metsch LR, Valverde EE, Del Rio C, Loughlin AM; Antiretroviral Treatment and Access Study (ARTAS) Study Group.

AIDS Care. 2007 Feb;19(2):195-202.

PMID:
17364398
5.

Linking recently diagnosed HIV-positive persons to medical care: perspectives of referring providers.

Gruber D, Campos P, Dutcher M, Safford L, Phillips K, Craw J, Gardner L.

AIDS Care. 2011 Jan;23(1):16-24. doi: 10.1080/09540121.2010.498865.

PMID:
21218273
6.

Demographic, psychological, and behavioral modifiers of the Antiretroviral Treatment Access Study (ARTAS) intervention.

Gardner LI, Marks G, Craw J, Metsch L, Strathdee S, Anderson-Mahoney P, del Rio C; Antiretroviral Treatment Access Study Group.

AIDS Patient Care STDS. 2009 Sep;23(9):735-42. doi: 10.1089/apc.2008.0262.

PMID:
19645619
7.

Structural factors and best practices in implementing a linkage to HIV care program using the ARTAS model.

Craw J, Gardner L, Rossman A, Gruber D, Noreen O, Jordan D, Rapp R, Simpson C, Phillips K.

BMC Health Serv Res. 2010 Aug 20;10:246. doi: 10.1186/1472-6963-10-246.

8.

Assessing receipt of medical care and disparity among persons with HIV/AIDS in San Francisco, 2006-2007.

Hsu LC, Chen M, Kali J, Pipkin S, Scheer S, Schwarcz S.

AIDS Care. 2011 Mar;23(3):383-92. doi: 10.1080/09540121.2010.507740.

PMID:
21347902
9.

Satisfaction with dental case management among people living with HIV/AIDS.

Lemay CA, Kretsedemas M, Graves JR.

J Community Health. 2010 Feb;35(1):43-52. doi: 10.1007/s10900-009-9195-z.

PMID:
19847630
10.

Virologic response differences between African Americans and European Americans initiating highly active antiretroviral therapy with equal access to care.

Weintrob AC, Grandits GA, Agan BK, Ganesan A, Landrum ML, Crum-Cianflone NF, Johnson EN, Ordóñez CE, Wortmann GW, Marconi VC; IDCRP HIV Working Group.

J Acquir Immune Defic Syndr. 2009 Dec;52(5):574-80. doi: 10.1097/QAI.0b013e3181b98537.

PMID:
19755913
11.

The "seeded" focus group: a strategy to recruit HIV+ community members into treatment research.

Busza J, Zaba B, Urassa M.

Sex Transm Infect. 2009 Jun;85(3):212-5. doi: 10.1136/sti.2008.029835. Epub 2008 Aug 6.

PMID:
18684857
12.

Support among persons infected with HIV for routine health department contact for HIV partner notification.

Golden MR, Hopkins SG, Morris M, Holmes KK, Handsfield HH.

J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):196-202.

PMID:
12571530
13.

Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users.

Wood E, Kerr T, Zhang R, Guillemi S, Palepu A, Hogg RS, Montaner JS.

HIV Med. 2008 Aug;9(7):503-7. doi: 10.1111/j.1468-1293.2008.00582.x. Epub 2008 May 15.

14.

Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment.

Roux P, Carrieri MP, Cohen J, Ravaux I, Poizot-Martin I, Dellamonica P, Spire B.

Clin Infect Dis. 2009 Nov 1;49(9):1433-40. doi: 10.1086/630209.

PMID:
19807275
15.

Psychological and behavioral correlates of entering care for HIV infection: the Antiretroviral Treatment Access Study (ARTAS).

Gardner LI, Marks G, Metsch LR, Loughlin AM, O'Daniels C, del Rio C, Anderson-Mahoney P, Wilkinson JD; ARTAS Study Group.

AIDS Patient Care STDS. 2007 Jun;21(6):418-25.

PMID:
17594251
16.

Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants and for French women?

Jasseron C, Mandelbrot L, Tubiana R, Teglas JP, Faye A, Dollfus C, Le Chenadec J, Rouzioux C, Blanche S, Warszawski J; ANRS French Perinatal Cohort.

AIDS. 2008 Jul 31;22(12):1503-11. doi: 10.1097/QAD.0b013e3283065b8c.

PMID:
18614874
17.

[Universal access, six years results in the Mexico City HIV/AIDS Program].

Soler Claudín C.

Salud Publica Mex. 2009 Jan-Feb;51(1):26-33. Spanish.

18.

An evaluation of a medical outreach program targeting unstably housed HIV-infected individuals.

Cunningham CO, Shapiro S, Berg KM, Sacajiu G, Paccione G, Goulet JL.

J Health Care Poor Underserved. 2005 Feb;16(1):127-38.

PMID:
15741714
19.

Gender and access to HIV testing and antiretroviral treatments in Thailand: why do women have more and earlier access?

Le Coeur S, Collins IJ, Pannetier J, Lelièvre E.

Soc Sci Med. 2009 Sep;69(6):846-53. doi: 10.1016/j.socscimed.2009.05.042. Epub 2009 Jul 1.

PMID:
19573965
20.

Risk factors for delayed initiation of medical care after diagnosis of human immunodeficiency virus.

Torian LV, Wiewel EW, Liu KL, Sackoff JE, Frieden TR.

Arch Intern Med. 2008 Jun 9;168(11):1181-7. doi: 10.1001/archinte.168.11.1181.

PMID:
18541826

Supplemental Content

Support Center